TAK-831
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for TAK-831, covering 2019-03-18 to 2021-04-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Absolute Bioavailability (ABA) of TAK-831 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]TAK-831 in Male Healthy Participants [Phase 1]